Avita Financial Statements From 2010 to 2025

Stocks . USA . 
Stock . Avita Medical
RCEL Stock  USD 9.25  0.22  2.44%   
Avita Medical financial statements provide useful quarterly and yearly information to potential Avita Medical investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on Avita Medical financial statements helps investors assess Avita Medical's valuation, profitability, and current liquidity needs. Key fundamental drivers impacting Avita Medical's valuation are summarized below:
Gross Profit
55.2 M
Profit Margin
(0.96)
Market Capitalization
238 M
Enterprise Value Revenue
3.8616
Revenue
64.3 M
There are over one hundred nineteen available fundamental signals for Avita Medical, which can be analyzed over time and compared to other ratios. We recommend to validate Avita Medical's prevailing fundamental drivers against the all of the trends between 2010 and 2025. At this time, Avita Medical's Working Capital is quite stable compared to the past year. Enterprise Value is expected to rise to about 131.1 M this year, although the value of Market Cap will most likely fall to about 126.3 M.

Avita Medical Total Revenue

67.46 Million

Check Avita Medical financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Avita Medical's main balance sheet or income statement drivers, such as Depreciation And Amortization of 1.8 M, Interest Expense of 5.6 M or Selling General Administrative of 96 M, as well as many indicators such as Price To Sales Ratio of 3.57, Dividend Yield of 0.0074 or PTB Ratio of 1.13. Avita financial statements analysis is a perfect complement when working with Avita Medical Valuation or Volatility modules.
  
Check out the analysis of Avita Medical Correlation against competitors.
For more information on how to buy Avita Stock please use our How to buy in Avita Stock guide.

Avita Medical Balance Sheet

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Total Assets83.7 M79.7 M55.5 M
Slightly volatile
Total Current Liabilities21.2 M20.2 M8 M
Slightly volatile
Total Stockholder Equity4.3 M4.5 M29.2 M
Slightly volatile
Cash13.6 M14.1 M21.6 M
Slightly volatile
Non Current Assets Total23.8 M22.7 M5.6 M
Slightly volatile
Cash And Short Term Investments140.7 M134 M48.6 M
Slightly volatile
Net Receivables12.4 M11.8 M3.5 M
Slightly volatile
Common Stock Shares Outstanding27.5 M26.2 M13.1 M
Slightly volatile
Liabilities And Stockholders Equity174.3 M166 M60.3 M
Slightly volatile
Non Current Liabilities Total57.8 M55.1 M11.2 M
Slightly volatile
Total Liabilities79 M75.2 M18 M
Slightly volatile
Total Current Assets59.9 M57 M51.5 M
Slightly volatile
Accumulated Other Comprehensive Income13.3 M12.7 M6 M
Slightly volatile
Common Stock4.8 K5.1 K63 M
Slightly volatile
Inventory7.6 M7.3 M2.4 M
Slightly volatile
Other Current Assets1.2 M1.9 M1.8 M
Pretty Stable
Accounts Payable6.6 M6.3 M2.9 M
Slightly volatile
Property Plant And Equipment Net14.3 M13.6 M3 M
Slightly volatile
Common Stock Total Equity3.3 K3.5 K63.8 M
Slightly volatile
Property Plant And Equipment Gross17.9 M17 M3.5 M
Slightly volatile
Property Plant Equipment1.7 M2.4 M2 M
Very volatile
Net Invested Capital61.5 M46.7 M34.6 M
Slightly volatile
Net Working Capital58.6 M36.8 M32.9 M
Slightly volatile
Capital Stock2.6 K2.7 K89.4 M
Slightly volatile

Avita Medical Income Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Depreciation And Amortization1.8 M1.7 M563.6 K
Slightly volatile
Selling General Administrative96 M91.4 M25.4 M
Slightly volatile
Other Operating Expenses108.3 M103.1 M37.5 M
Slightly volatile
Total Operating Expenses126.9 M120.8 M40.5 M
Slightly volatile
Total Revenue67.5 M64.3 M17.3 M
Slightly volatile
Gross Profit57.9 M55.2 M14.4 M
Slightly volatile
Selling And Marketing Expenses38.9 M37 M13.7 M
Slightly volatile
Cost Of Revenue9.5 M9.1 M2.9 M
Slightly volatile
Research Development21.4 M20.4 M9.4 M
Slightly volatile
Interest Income67.6 K43.4 K75.4 K
Slightly volatile
Reconciled Depreciation1.2 M1.1 M393.8 K
Slightly volatile

Avita Medical Cash Flow Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Begin Period Cash Flow15.9 M22.1 M27.2 M
Very volatile
Depreciation1.2 M1.1 M482.1 K
Slightly volatile
Stock Based Compensation14.2 M13.5 M6 M
Slightly volatile

Financial Ratios

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Price To Sales Ratio3.573.7523.9171
Slightly volatile
Dividend Yield0.00740.00780.0088
Slightly volatile
PTB Ratio1.131.194.066
Slightly volatile
Days Sales Outstanding40.9143.0690.7059
Slightly volatile
Book Value Per Share5.445.733.7257
Slightly volatile
Invested Capital4.5 M7.4 M8 M
Slightly volatile
Stock Based Compensation To Revenue0.170.180.5334
Very volatile
Capex To Depreciation0.70.721.123
Very volatile
PB Ratio1.131.194.066
Slightly volatile
EV To Sales3.03.1620.5441
Slightly volatile
Inventory Turnover2.713.272.8676
Pretty Stable
Days Of Inventory On Hand110116342
Slightly volatile
Payables Turnover1.562.311.3952
Pretty Stable
Sales General And Administrative To Revenue0.740.783.1586
Slightly volatile
Research And Ddevelopement To Revenue0.340.361.6385
Pretty Stable
Capex To Revenue0.01430.01510.0925
Slightly volatile
Cash Per Share2.44.23.0173
Slightly volatile
Days Payables Outstanding325163403
Slightly volatile
Net Current Asset Value2.9 M2.2 M2.5 M
Very volatile
Income Quality0.460.640.7854
Slightly volatile
Tangible Asset Value4.1 M2.4 M2.8 M
Slightly volatile
Intangibles To Total Assets0.00520.00540.0444
Slightly volatile
Net Debt To EBITDA0.630.60.8746
Very volatile
Current Ratio12.549.417.1878
Slightly volatile
Tangible Book Value Per Share5.415.693.4795
Slightly volatile
Receivables Turnover9.4911.216.0734
Slightly volatile
Shareholders Equity Per Share5.445.733.7257
Slightly volatile
Debt To Equity0.00310.00330.0092
Very volatile
Capex Per Share0.0290.03050.0356
Pretty Stable
Graham Net Net4.044.72.8043
Slightly volatile
Revenue Per Share2.442.331.1114
Slightly volatile
Interest Debt Per Share0.01960.02070.0361
Pretty Stable
Debt To Assets0.00270.00280.0079
Very volatile
Average Payables102.7 K108.1 K1.4 M
Very volatile
Average Inventory12.6 K13.3 K679.9 K
Slightly volatile
Average Receivables400.9 K238.2 K435.2 K
Slightly volatile
Graham Number77.1486.7994.6242
Slightly volatile
Operating Cycle142149432
Slightly volatile
Price Book Value Ratio1.131.194.066
Slightly volatile
Days Of Payables Outstanding325163403
Slightly volatile
Ebt Per Ebit1.061.111.0104
Very volatile
Company Equity Multiplier0.941.041.1874
Slightly volatile
Long Term Debt To Capitalization0.00390.00410.011
Pretty Stable
Total Debt To Capitalization0.00310.00320.0091
Very volatile
Debt Equity Ratio0.00310.00330.0092
Very volatile
Quick Ratio12.289.186.8955
Slightly volatile
Net Income Per E B T1.691.151.0139
Slightly volatile
Cash Ratio1.861.953.927
Very volatile
Days Of Inventory Outstanding110116342
Slightly volatile
Days Of Sales Outstanding40.9143.0690.7059
Slightly volatile
Free Cash Flow Operating Cash Flow Ratio1.131.181.039
Slightly volatile
Price To Book Ratio1.131.194.066
Slightly volatile
Fixed Asset Turnover10.0215.111.9752
Pretty Stable
Debt Ratio0.00270.00280.0079
Very volatile
Price Sales Ratio3.573.7523.9171
Slightly volatile
Asset Turnover0.330.320.2291
Slightly volatile
Price Fair Value1.131.194.066
Slightly volatile

Avita Medical Valuation Data

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Market Cap126.3 M148.5 M207.2 M
Slightly volatile
Working Capital3.1 M2.3 M2.6 M
Pretty Stable
Enterprise Value131.1 M124.9 M174.3 M
Slightly volatile

Avita Fundamental Market Drivers

Forward Price Earnings151.5152

Avita Upcoming Events

22nd of February 2024
Upcoming Quarterly Report
View
9th of May 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
22nd of February 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

About Avita Medical Financial Statements

Avita Medical investors utilize fundamental indicators, such as revenue or net income, to predict how Avita Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
Last ReportedProjected for Next Year
Current Deferred Revenue223.1 K345.6 K
Total Revenue64.3 M67.5 M
Cost Of Revenue9.1 M9.5 M
Stock Based Compensation To Revenue 0.18  0.17 
Sales General And Administrative To Revenue 0.78  0.74 
Research And Ddevelopement To Revenue 0.36  0.34 
Capex To Revenue 0.02  0.01 
Revenue Per Share 2.33  2.44 
Ebit Per Revenue(0.92)(0.96)

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect
When determining whether Avita Medical is a strong investment it is important to analyze Avita Medical's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Avita Medical's future performance. For an informed investment choice regarding Avita Stock, refer to the following important reports:
How To Invest In Avita
Details
Is Avita Stock a good investment?
Details
What is Avita Medical's Net Worth?
Details
Largest Biotechnology Companies
View
Largest Pharmaceuticals, Biotechnology & Life Sciences Companies
View
Check out the analysis of Avita Medical Correlation against competitors.
For more information on how to buy Avita Stock please use our How to buy in Avita Stock guide.
You can also try the Portfolio Optimization module to compute new portfolio that will generate highest expected return given your specified tolerance for risk.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Avita Medical. If investors know Avita will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Avita Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(2.39)
Revenue Per Share
2.482
Quarterly Revenue Growth
0.297
Return On Assets
(0.37)
Return On Equity
(2.31)
The market value of Avita Medical is measured differently than its book value, which is the value of Avita that is recorded on the company's balance sheet. Investors also form their own opinion of Avita Medical's value that differs from its market value or its book value, called intrinsic value, which is Avita Medical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Avita Medical's market value can be influenced by many factors that don't directly affect Avita Medical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Altman
Z Score
Details
Piotroski
F Score
Details
Beneish
M Score
Details
Financial
Analysis
Details
Buy or Sell
Advice
Details
Earnings
Projections
Details
Please note, there is a significant difference between Avita Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Avita Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Avita Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2024 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY